We are glad to inform you that the Glucophage case study is now online. Learn why BIOFEM Pharmaceuticals Ltd., sole distributors of Merck products in Nigeria, signed on to use Sproxil’s MPA technology and how they increased their sales by over 10% in just 100 days. From the case study:

Since 2008, Glucophage sales had fallen by 75%, “more or less the main reason being counterfeit drugs,” according to Merck spokesperson Gangolf Schrimpf.  After  just 100 days of  using Sproxil’s solution, Glucophage sales in Nigeria increased by over 10%.